Murphy Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.98M | Sell |
38,715
-888
| -2% | -$67.6K | 0.41% | 57 |
|
|
2022
Q1 | $2.89M | Sell |
39,603
-2,077
| -5% | -$139K | 0.33% | 65 |
|
|
2021
Q4 | $2.6M | Sell |
41,680
-5,462
| -12% | -$320K | 0.28% | 71 |
|
|
2021
Q3 | $2.79M | Sell |
47,142
-2,724
| -5% | -$179K | 0.33% | 67 |
|
|
2021
Q2 | $3.33M | Buy |
49,866
+1,495
| +3% | +$97.5K | 0.38% | 63 |
|
|
2021
Q1 | $3.05M | Buy |
48,371
+3,026
| +7% | +$188K | 0.38% | 62 |
|
|
2020
Q4 | $2.81M | Sell |
45,345
-1,815
| -4% | -$112K | 0.37% | 62 |
|
|
2020
Q3 | $2.84M | Buy |
47,160
+2,273
| +5% | +$137K | 0.41% | 59 |
|
|
2020
Q2 | $2.64M | Buy |
44,887
+1,208
| +3% | +$72.3K | 0.42% | 61 |
|
|
2020
Q1 | $2.43M | Sell |
43,679
-5,485
| -11% | -$335K | 0.46% | 58 |
|
|
2019
Q4 | $3.15M | Buy |
49,164
+16,090
| +49% | +$921K | 0.45% | 60 |
|
|
2019
Q3 | $1.68M | Sell |
33,074
-1,163
| -3% | -$54.7K | 0.25% | 93 |
|
|
2019
Q2 | $1.55M | Sell |
34,237
-19,882
| -37% | -$926K | 0.23% | 98 |
|
|
2019
Q1 | $2.58M | Sell |
54,119
-9,856
| -15% | -$491K | 0.39% | 68 |
|
|
2018
Q4 | $3.33M | Sell |
63,975
-3,315
| -5% | -$178K | 0.56% | 49 |
|
|
2018
Q3 | $4.18M | Sell |
67,290
-5,405
| -7% | -$321K | 0.58% | 50 |
|
|
2018
Q2 | $4.02M | Sell |
72,695
-1,122
| -2% | -$60.6K | 0.58% | 50 |
|
|
2018
Q1 | $4.67M | Sell |
73,817
-6,002
| -8% | -$386K | 0.66% | 45 |
|
|
2017
Q4 | $4.89M | Sell |
79,819
-273
| -0.3% | -$17.1K | 0.67% | 45 |
|
|
2017
Q3 | $5.11M | Sell |
80,092
-155
| -0.2% | -$9.05K | 0.73% | 43 |
|
|
2017
Q2 | $4.47M | Sell |
80,247
-2,297
| -3% | -$125K | 0.66% | 49 |
|
|
2017
Q1 | $4.49M | Buy |
82,544
+37,481
| +83% | +$2.06M | 0.67% | 48 |
|
|
2016
Q4 | $2.63M | Buy |
45,063
+4,929
| +12% | +$269K | 0.42% | 70 |
|
|
2016
Q3 | $2.16M | Buy |
40,134
+2,920
| +8% | +$188K | 0.34% | 80 |
|
|
2016
Q2 | $2.74M | Sell |
37,214
-190
| -0.5% | -$13.4K | 0.42% | 61 |
|
|
2016
Q1 | $2.39M | Sell |
37,404
-1,866
| -5% | -$118K | 0.37% | 70 |
|
|
2015
Q4 | $2.7M | Buy |
39,270
+1,108
| +3% | +$73.2K | 0.41% | 65 |
|
|
2015
Q3 | $2.26M | Sell |
38,162
-50
| -0.1% | -$3.17K | 0.37% | 72 |
|
|
2015
Q2 | $2.54M | Sell |
38,212
-1,210
| -3% | -$79.7K | 0.38% | 76 |
|
|
2015
Q1 | $2.54M | Sell |
39,422
-3,409
| -8% | -$213K | 0.38% | 76 |
|
|
2014
Q4 | $2.53M | Sell |
42,831
-5,650
| -12% | -$319K | 0.39% | 76 |
|
|
2014
Q3 | $2.48M | Sell |
48,481
-1,435
| -3% | -$71.7K | 0.39% | 72 |
|
|
2014
Q2 | $2.42M | Buy |
49,916
+2,968
| +6% | +$146K | 0.38% | 71 |
|
|
2014
Q1 | $2.44M | Sell |
46,948
-163
| -0.3% | -$8.67K | 0.41% | 72 |
|
|
2013
Q4 | $2.5M | Buy |
47,111
+3,263
| +7% | +$166K | 0.44% | 67 |
|
|
2013
Q3 | $2.03M | Buy |
43,848
+10,015
| +30% | +$440K | 0.38% | 76 |
|
|
2013
Q2 | $1.51M | Buy |
+33,833
| New | +$1.47M | 0.31% | 86 |
|
Other funds holding BMY
Murphy Capital Management's BMY Position: Q2 2022 in Review
Murphy Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2022, selling an estimated $67.6K and leaving 38,715 shares worth $2.98M. The position accounts for 0.41% of the portfolio, ranked #57.
Murphy Capital Management first reported a position in BMY in Q2 2013 and has held it in 37 quarters since. The position peaked at $5.11M in Q3 2017. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Murphy Capital Management held 38,715 shares of Bristol-Myers Squibb worth $2.98M as of Q2 2022.
- Murphy Capital Management sold 888 Bristol-Myers Squibb shares in Q2 2022, an estimated $67.6K.
- Bristol-Myers Squibb made up 0.41% of Murphy Capital Management's portfolio in Q2 2022, its #57 holding.
- Murphy Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 37 quarters since.
- Murphy Capital Management's Bristol-Myers Squibb position peaked at $5.11M in Q3 2017.
- 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.